TZ Limited Completes Entitlement Offer and Advances Capital Raising Plan
TZ Limited (ASX: TZL) has completed its non-renounceable entitlement offer, marking another step in its broader capital raising strategy aimed at supporting future growth and strengthening its financial position. The offer attracted valid applications for 4,042,731 new fully paid ordinary shares, including 3,797,340 shares taken up through shareholder entitlements and 245,391 additional shares, generating approximately AU$121,282 before costs.
Despite the completion of the offer, around 81.93 million shares remain unsubscribed and have been designated as shortfall shares. The company intends to actively market these shares to eligible shareholders as well as sophisticated and professional investors over the next three months at the same issue price of AU$0.03 per share, subject to applicable regulations. Any shares not placed within this period will lapse. Settlement of the new shares is scheduled for 14 July 2026, followed by allotment on 15 July 2026, completing this phase of the capital raising process.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
TZ Limited Completes Entitlement Offer and Advances Capital Raising Plan
TZ Limited (ASX: TZL) has completed its non-renounceable entitlement offer, marking another step in its broader capital raising strategy aimed at supporting future growth and strengthening its financial position. The offer attracted valid applications for 4,042,731 new fully paid ordinary shares, including 3,797,340 shares taken up through shareholder entitlements and 245,391 additional shares, generating approximately AU$121,282 before costs.
Despite the completion of the offer, around 81.93 million shares remain unsubscribed and have been designated as shortfall shares. The company intends to actively market these shares to eligible shareholders as well as sophisticated and professional investors over the next three months at the same issue price of AU$0.03 per share, subject to applicable regulations. Any shares not placed within this period will lapse. Settlement of the new shares is scheduled for 14 July 2026, followed by allotment on 15 July 2026, completing this phase of the capital raising process.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au